{"doi":"10.1007/s10882-025-10033-9","title":"Exploring Parent Perspectives of Feasibility After Intensive Telerehabilitation for Children with Unilateral Cerebral Palsy: A Mixed Methods Study","abstract":"= 12) received 20 sessions (daily, 3 h each) of telehealth pCIMT over 4 weeks. Quantitative data was collected using the Feasibility, Acceptability, and Appropriateness of Intervention Measure (FIM, AIM, IAM) and Usefulness, Usability and Desirability (UUD). Qualitative data was collected via semi-structured, post-treatment, parent interviews and coded using inductive content analysis and constant comparison. Quantitative and qualitative results support feasibility, acceptability, and appropriateness of telehealth pCIMT and usefulness, usability, and desirability of study technology. Median scores on Feasibility, Acceptability, and Appropriateness of Intervention Measure (out of 20 possible points) were 20 (IQR = 5.75), 18.5 (IQR = 3.75) and 20 (IQR = 4), respectively; median ratings on the Usefulness, Usability and Desirability Assessment (7 point likert scale 1-7) were 6 (IQR = 1), 6.5 (IQR = 1), and 6 (IQR = 2.5) respectively. Content analysis of parent interviews yielded three categories: Implementation Potential, Advantages and Disadvantages, and Logistical Considerations. Telehealth pCIMT was feasible, acceptable, and appropriate but is not without challenges. A demonstration of the efficacy of telehealth pCIMT is needed. Registered on Clinicaltrials.gov on 3/21/2022 with ID NCT05303883. Supplementary Information: The online version contains supplementary material available at 10.1007/s10882-025-10033-9.","journal":"Journal of Developmental and Physical Disabilities","year":2025,"id":554017,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8872,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT05303883"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1451358,"name":"Angela Rittler","orcid":null,"position":1,"is_corresponding":false},{"id":1451359,"name":"K Amon","orcid":null,"position":2,"is_corresponding":false},{"id":569013,"name":"Jill Heathcock","orcid":"0000-0002-2241-1332","position":3,"is_corresponding":false},{"id":42514,"name":"Warren Lo","orcid":"0000-0002-8079-8977","position":4,"is_corresponding":false},{"id":1450883,"name":"Stephanie DeLuca","orcid":"0000-0002-7366-7477","position":5,"is_corresponding":false},{"id":1306966,"name":"Amy Darragh","orcid":null,"position":6,"is_corresponding":false},{"id":1450882,"name":"Elizabeth Maus","orcid":"0000-0001-7069-7585","position":0,"is_corresponding":true}],"reference_count":51,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:54:45.872391Z","pmid":"42221522","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}